Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Antipsychotics
84%
Nave
78%
Healthy Controls
60%
Functional Magnetic Resonance Imaging
53%
Cerebral Blood Flow
52%
Schizophrenic
50%
First-episode Psychosis
47%
White Matter
41%
Schizophrenia
37%
White Matter Hyperintensities
33%
Cardiac Magnetic Resonance Imaging (cMRI)
30%
Psychosis
28%
Glutamate Level
27%
Glutamate
23%
Leukoaraiosis
20%
Antipsychotic Treatment
20%
Patients with Schizophrenia
19%
Regional Cerebral Blood Flow (rCBF)
19%
Age-related
18%
First Episode
18%
Resting Cerebral Blood Flow
17%
Perfusion
17%
Disability Studies
17%
Positron Emission Tomography/computed Tomography (PET/CT)
16%
Anterior Cingulate Cortex
16%
Cerebral Perfusion
16%
Visual Stimulation
15%
Dopamine D2/3 Receptor
15%
Corpus Callosum Agenesis
15%
Multiple Sclerosis
15%
Positive Symptoms
15%
γ-aminobutyric Acid
14%
Striatal
14%
Corpus Callosum
14%
Clinical Outcomes
14%
Cognitive Function
13%
Blood Oxygen Level-dependent
13%
Functional Connectivity
13%
Psychotic Symptoms
13%
Treatment Response
12%
Receptor Blockade
12%
Ultra-high Risk for Psychosis
12%
Migraine Aura
12%
Electroconvulsive Therapy
12%
Healthy Volunteers
12%
Cerebral Blood Volume
12%
Amisulpride
11%
Fractional Anisotropy
11%
Control Subjects
11%
Disability
11%
Neuroscience
Antipsychotic
100%
Schizophrenia
92%
Magnetic Resonance Imaging
76%
Functional Magnetic Resonance Imaging
65%
Psychosis
48%
Glutamic Acid
35%
Dopamine
31%
Longitudinal Study
28%
Gamma-Aminobutyric Acid
23%
Cognitive Disorders
22%
Thalamus
22%
Positive Syndrome
22%
Cognitive Function
21%
Migraine
19%
Anterior Cingulate Cortex
18%
Leukoaraiosis
17%
Receptor
16%
Negative Syndrome
16%
Psychopathology
16%
Arterial Spin Labeling
16%
Gray Matter
16%
Auras
16%
Multiple Sclerosis
15%
Corpus Callosum Atrophy
15%
Corpus Callosum
15%
Fractional Anisotropy
15%
Positron Emission Tomography
13%
Functional Connectivity
13%
Reward System
12%
Risk Factor
12%
Electroconvulsive Therapy
12%
Cortical Thickness
11%
Cognitive Decline
11%
Amisulpride
11%
Visual Cortex
10%
Gray Matter Volume
10%
Diffusion Tensor Imaging
10%
Hippocampus
10%
Electroencephalography
9%
Putamen
9%
Temporal Lobe
9%
Posttraumatic Stress Disorder
9%
Neurotrauma
9%
Traumatic Brain Injury
9%
Human Brain
9%
Brain Structure
9%
Brain Region
8%
Muscular Dystrophy
8%
Frontal Lobe
8%
Working Memory
7%
